SCHEMBL6727481

SCHEMBL6727481

CC(C)OC(Cc1ccccc1COC(=O)Nc1ccc(N(C)C)cc1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.47
ALDH1A1 P00352 6/20 0.47
KMT2A Q03164 6/20 0.47
MEN1 O00255 5/20 0.47
KDM4E B2RXH2 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
THRB P10828 1/20 0.47
GFER P55789 1/20 0.47
SMN1; SMN2 Q16637 5/20 0.46
NPC1 O15118 5/20 0.46
RAB9A P51151 5/20 0.46
MCL1 Q07820 4/20 0.46
MAPK1 P28482 3/20 0.46
HPGD P15428 2/20 0.46
NOX1 Q9Y5S8 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
LMNA P02545 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4329791 0.90 LMNA (0.44) MAPTALDH1A1KMT2AMEN1TDP1
SCHEMBL4341658 0.88 MAPT (0.48) MAPTALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL4327192 0.87 CYP1A2 (0.56) MAPTALDH1A1KMT2AMEN1KDM4E
SCHEMBL4335538 0.87 KMT2A (0.45) MAPTALDH1A1KMT2AMEN1KDM4E
SCHEMBL4335160 0.86 LMNA (0.48) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL4332195 0.85 ALDH1A1 (0.47) MAPTALDH1A1KMT2AMEN1KDM4E
SCHEMBL4341925 0.84 ALDH1A1 (0.40) MAPTALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL4328015 0.84 NPC1 (0.47) MAPTALDH1A1KMT2AMEN1KDM4E
SCHEMBL4334182 0.84 MGLL (0.45) MAPTALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL4335130 0.82 FPR2 (0.47) ALDH1A1KMT2AMEN1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 MAPT 4654/4885ALDH1A1 844/4885KMT2A 2774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.